Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2003
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/18/2003CA2478945A1 Cyclic amides
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478701A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/17/2003EP1343796A2 Compounds and methods
09/17/2003EP1343782A1 Pyrimidineamines as angiogenesis modulators
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343771A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343761A1 Piperidine mch antagonists and their use in the treatment of obesity
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343505A1 Cxcr3 antagonists
09/17/2003EP1343499A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP1177194B1 4-(3',4'-heterocyclyl benzoyl) pyrazoles as herbicidal agents
09/17/2003EP1030852B1 Oxazolidinone derivatives and pharmaceutical compositions
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003CN1443178A (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphtyl] -4-morpholibenzamide
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1443156A Preparation of 4-thioalkylbromobenzene derivatives
09/17/2003CN1442416A Helerocyclic substituted benzoxazine cyclic compound having biological activity
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1121404C Antifungal agent and its preparing process and intermediate
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/17/2003CN1121396C Substituted phenyltriazolin (thi) ones and their use as herbicides
09/17/2003CN1121393C Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof
09/17/2003CN1121391C Substituted 3-cyano quinolines
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620941 Process for the preparation of thiazolidinedione derivatives
09/16/2003US6620827 PPARγ modulators
09/16/2003US6620815 Oxazolidinones and uses thereof
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003CA2261271C Dihydrodibenzo[b,e]oxazepine derivatives and pharmaceutical composition containing the same
09/16/2003CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2003074519A1 Coumarines useful as biomarkers
09/12/2003WO2003074517A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity
09/12/2003WO2003074516A1 Phthalimide carboxylic acid derivatives
09/12/2003WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074498A1 Cyclic compound, process for producing the same, and pest control agent
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074484A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074476A1 Novel arylamidine derivative or salt thereof
09/12/2003WO2003074053A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003WO2003053960A3 Quinline derivates and their use as mek inhibitors
09/12/2003WO2003048081A3 Glycinamides as factor xa inhibitors
09/12/2003WO2001083800A9 Heterologous production of polyketides
09/12/2003CA2481307A1 Phthalimide carboxylic acid derivatives
09/12/2003CA2477717A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477403A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003CA2472298A1 Coumarines useful as biomarkers
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171621 Process for the synthesis of sphingosine
09/11/2003US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/11/2003US20030171595 Thienylsulphonylamino(thio)carbonyl compounds
09/11/2003US20030171579 N-benzyl-N'-phenylurea derivatives; inhibitors of the coagulation factors Xa and VIIa
09/11/2003US20030171428 Anticancer agents; anticholesterol agents; cognition activators; rheumatic diseases
09/11/2003US20030171413 Rheumatic diseases; antiarthritic agents; asthma
09/11/2003US20030171403 Blockade of voltage dependent sodium channels
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171386 Small molecules for the treatment of abnormal cell growth
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171374 Viricides; prevent reproduction of human T-Cell lymphocyte virus
09/11/2003US20030171366 Having antibacterial activity against Gram-positive and Gram-negative bacteria
09/11/2003US20030171362 Amino-tetralin derivatives as muscarinic receptor antagonists
09/11/2003US20030171360 Piperidines
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171331 Oxazolidinone cotherapy
09/11/2003US20030171218 Substituted 3-heteroaryl(amino- or oxy) pyrrolidin-2-ones of the formula (I), processes for preparing them, and their use as herbicides or as plant growth regulators.
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341760A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1187856B1 Transition metal complexes and olefin polymerization process
09/10/2003EP1135388B1 3-(heterocyclyl)-substituted benzoylpyrazols
09/10/2003EP1057827B1 Spiropiperidine derivatives
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441799A New thiochromane derivatives and use as thrombin inhibitors
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1440962A Substituted amino amide salicylate with Fungal killing function and tis prepared intermediate thereof
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 647